Is Chloroquine enough on the Global Market?
Hydroxychloroquine is very similar to chloroquine, one of the oldest and best-known anti-malarial drugs.
As interest in these drugs has grown as a potential treatment for Covid-19, many countries have seen high demand and shortages.
Chloroquine and its derivatives have long been widely available in pharmacies, particularly in developing countries, for the treatment of malaria.
This is despite their declining efficacy against malaria, as the disease has become increasingly resistant.
Jordan has banned the sale of hydroxychloroquine in pharmacies to prevent stockpiling. Similarly, the Kuwaiti Health Ministry decided to withdraw all medicines containing the drugs from private pharmacies and limit them to hospitals and health centres.
Kenya has banned over-the-counter sales of chloroquine, so it is now only available on prescription.
India is a major producer of these antimalarial drugs, and has imposed a ban on exports.
President Trump has made a personal plea to India’s Prime Minister, Narendra Modi, for access to the drugs for use in the United States. Now India is considering the request.